Replies to post #372976 on Amarin Corp Plc (AMRN)

[Whalatane]

What don’t U understand ?
AMRN is losing market share to the generics in the US and we don’t have EU / UK decisions yet on the extent of reimbursement for Vazkepa .
Meanwhile investors are heading to cash because of the war in Ukraine and the Covid lock downs in China

Kiwi